Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREOB in Severe Osteoporosis
NCT02061995Phase 2Completed
- Sponsor
- Erasmus Hospital
- Start
- Dec 2013
- Primary completion
- Oct 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of PREOB in osteoporosis, sponsored by Erasmus Hospital. Primary endpoints: Cell biodistribution at 72 hours and Adverse Events at 12 months. Started Dec 2013; status: completed.
02
Drugs
PREOB
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02061995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061995.